GeneSystem Co Ltd
KOSDAQ:363250
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
G
|
GeneSystem Co Ltd
KOSDAQ:363250
|
34.7B KRW |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
389.4B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197B USD |
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
193.8B USD |
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
116.6B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.4B USD |
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
74.1B AUD |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.2B EUR |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
GeneSystem Co Ltd
Glance View
Genesystem Co., Ltd engages in providing PCR based molecular diagnostic products. The firm is engaged in the development, manufacture and sale of platform based on molecular diagnosis. The firm develops and manufactures products such as molecular diagnosis systems, biochips, test kits, and reaction reagents, among others. The firm develops in vitro diagnostic technology through immunodiagnosis technology and molecular diagnosis technology.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for GeneSystem Co Ltd is -646.5%, which is below its 3-year median of -181.3%.
Over the last 3 years, GeneSystem Co Ltd’s Gross Margin has decreased from 55.1% to -646.5%. During this period, it reached a low of -646.5% on Sep 30, 2025 and a high of 55.1% on Sep 30, 2022.
